Article thumbnail

PCN62 COST ANALYSIS OF HORMONE RECEPTOR POSITIVE, ADVANCED BREAST CANCER TREATMENT WITH ENDOCRINE THERAPY VERSUS CHEMOTHERAPY IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM (BPHS)

By E Abdo Filho, M Takemoto, VD Teich, FF Quintella, RA Fernandes, RBF Passos, N Teich, AP Silva, M Marques, J Mottola Jr, LH Gebrim, SE Picinini and M Sakano
Publisher: International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
Year: 2009
DOI identifier: 10.1016/S1098-3015(10)74313-8
OAI identifier:

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.